Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells
Open Access
- 22 April 2008
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 84 (1) , 124-133
Abstract
Promising immunotherapeutic tools for T cell-mediated pathologies are alternatively activated dendritic cells (aaDC), which exert their effect through the regulation and tolerization of T cells. As naïve and memory T cells have different susceptibilities to tolerogenic signals, it is important to understand the modulatory effects of aaDC on these T cell subsets. We have examined regulation of naïve and memory CD4+ T cells by human aaDC generated with dexamethasone, the active form of vitamin D3, 1α,25-dihydroxyvitamin D3, and LPS. Although aaDC induced low, primary, allogeneic responses by naïve and memory T cells, aaDC regulated the differentiation of these T cell subsets in a distinct manner. Naïve T cells primed by aaDC retained a strong, proliferative capacity upon restimulation but were skewed toward a low IFN-γ/high IL-10 cytokine profile. In contrast, memory T cells primed by aaDC became hyporesponsive in terms of proliferation and cytokine production. Induction of anergy in memory T cells by aaDC was not a result of the presence of CD25hi regulatory T cells and could be partially reversed by IL-2. Both T cell subsets acquired regulatory activity and inhibited primary CD4 and CD8 responses. Addition of exogenous IL-12p70 during T cell priming by aaDC prevented anergy induction in memory T cells and cytokine polarization in naïve T cells, indicating that the lack of IL-12p70 is a key feature of aaDC. Our finding that aaDC differentially regulate naïve and memory T cells is important for understanding and maximizing the therapeutic potential of aaDC.Keywords
Funding Information
- Arthritis Research Campaign (17750)
- Action Medical Research (RTF1155)
This publication has 53 references indexed in Scilit:
- Transient regulatory T-cells: A state attained by all activated human T-cellsClinical Immunology, 2007
- Transient expression of FOXP3 in human activated nonregulatory CD4+ T cellsEuropean Journal of Immunology, 2006
- Maturation-Resistant Dendritic Cells Induce Hyporesponsiveness in Alloreactive CD45RA+ and CD45RO+ T-Cell PopulationsAmerican Journal of Transplantation, 2006
- Dendritic Cells Activated by Lipopolysaccharide after Dexamethasone Treatment Induce Donor-Specific Allograft HyporesponsivenessTransplantation, 2006
- Antigen‐specific immunomodulation of collagen‐induced arthritis with tumor necrosis factor–stimulated dendritic cellsArthritis & Rheumatism, 2004
- Pharmacological induction of tolerogenic dendritic cells and regulatory T cellsSeminars in Immunology, 2004
- Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells1Transplantation, 2003
- Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioningTransplant Immunology, 2003
- Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from AutoimmunityJournal of Experimental Medicine, 2001
- Prolongation of Cardiac Allograft Survival Using Dendritic Cells Treated with NF-κB Decoy OligodeoxyribonucleotidesMolecular Therapy, 2000